Frazier Life Sciences Management L.P. Grows Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

Frazier Life Sciences Management L.P. lifted its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) by 0.4% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 6,495,392 shares of the company’s stock after buying an additional 25,000 shares during the quarter. Mirum Pharmaceuticals makes up about 10.3% of Frazier Life Sciences Management L.P.’s […]

Related Keywords

United States ,China ,Stifel Nicolaus ,Eric Bjerkholt ,Saira Ramasastry ,News Ratings For Mirum Pharmaceuticals Daily ,Wetzel Investment Advisors Inc ,Quest Partners ,Nasdaq ,China Universal Asset Management Co ,Stepstone Group ,Insider Transactions At Mirum Pharmaceuticals ,Quarter For Mirum Pharmaceuticals ,Morgan Stanley ,Mirum Pharmaceuticals Stock Down ,Mirum Pharmaceuticals ,Cantor Fitzgerald ,Exchange Commission ,Frazier Life Sciences Management ,Mirum Pharmaceuticals Profile ,Citigroup ,Mirum Pharmaceuticals Inc ,Free Report ,Investment Advisors ,Stone Group ,Universal Asset Management ,Director Saira Ramasastry ,Pharmaceuticals Stock Down ,Get Free Report ,Visit Holdingschannel ,Mirum Pharmaceuticals Daily ,